Analyst firms · Evercore ISI · NVCR

Evercore ISI NVCR price target and rating history

NovoCure Limited (NVCR) · Health Care

Evercore ISI rates NovoCure Limited (NVCR) Outperform with a $30 price target, as of its latest action on Dec 2, 2024. It has published 4 rating actions on NVCR since January 2022, including 3 upgrades and 1 downgrade.

Current rating
Outperform
Price target
$30
Median target, all firms
Too few
Actions on NVCR
4

Evercore ISI price target on NVCR

$82$56$302023202420252026
Evercore ISI price target on NVCR, each point a stated target, January 2022 to December 2024.

Every Evercore ISI rating on NVCR

Questions about Evercore ISI and NVCR

What is Evercore ISI's price target for NVCR?
Evercore ISI's latest stated price target for NovoCure Limited (NVCR) is $30, from its action on Dec 2, 2024.
What is Evercore ISI's rating on NVCR?
Evercore ISI rates NVCR Outperform, a bullish rating, as of Dec 2, 2024.
When did Evercore ISI last change its view on NVCR?
On Dec 2, 2024, Evercore ISI upgrades to Outperform from In-line, price target $18 to $30.

More NVCR rating histories

All Evercore ISI ratingsNVCR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.